ALLMedicine™ Fructosamine Center
Research & Reviews 291 results
https://clinicaltrials.gov/ct2/show/NCT02053272
Dec 20th, 2022 - This 14 week (one week baseline, 12 week treatment period and one week follow-up), multicentre, randomised, double blind, placebo controlled, parallel group study will evaluate the efficacy, safety and tolerability of 2, 5 and 15 mg of GWP42004 as...
https://doi.org/10.1016/j.jconrel.2022.12.012
Journal of Controlled Release : Official Journal of the C... Ganugula R, Nuthalapati NK et. al.
Dec 13th, 2022 - Treatments for diabetic kidney disease (DKD) mainly focus on managing hyperglycemia and hypertension, but emerging evidence suggests that inflammation also plays a role in the pathogenesis of DKD. This 10-week study evaluated the efficacy of daily...
https://clinicaltrials.gov/ct2/show/NCT04473378
Nov 18th, 2022 - This is a prospective observational cohort study monitoring trends in glucose in patients with early stage breast cancer treated with neoadjuvant or adjuvant chemotherapy. Patients will wear a noninvasive glucose monitoring sensor, the Freestyle L...
https://clinicaltrials.gov/ct2/show/NCT05571670
Oct 10th, 2022 - The primary objective of this study is to determine the effect of drug-induced acute insulin resistance (diaIR) on the ratio of 12α-hydroxylated bile acids (12-HBA) to 12α-hydroxylated bile acids (non-12-HBA) in cancer patients treated with phosph...
https://clinicaltrials.gov/ct2/show/NCT03505762
Oct 10th, 2022 - PRIMARY OBJECTIVES: I. To compare the cumulative incidence of hyperglycemia after 3 cycles of treatment between standard or tailored rituximab, cyclophosphamide, doxorubicin hydrochloride, vincristine sulfate and prednisone (R-CHOP) chemotherapy. ...
Clinicaltrials.gov 60 results
https://clinicaltrials.gov/ct2/show/NCT02053272
Dec 20th, 2022 - This 14 week (one week baseline, 12 week treatment period and one week follow-up), multicentre, randomised, double blind, placebo controlled, parallel group study will evaluate the efficacy, safety and tolerability of 2, 5 and 15 mg of GWP42004 as...
https://clinicaltrials.gov/ct2/show/NCT04473378
Nov 18th, 2022 - This is a prospective observational cohort study monitoring trends in glucose in patients with early stage breast cancer treated with neoadjuvant or adjuvant chemotherapy. Patients will wear a noninvasive glucose monitoring sensor, the Freestyle L...
https://clinicaltrials.gov/ct2/show/NCT05571670
Oct 10th, 2022 - The primary objective of this study is to determine the effect of drug-induced acute insulin resistance (diaIR) on the ratio of 12α-hydroxylated bile acids (12-HBA) to 12α-hydroxylated bile acids (non-12-HBA) in cancer patients treated with phosph...
https://clinicaltrials.gov/ct2/show/NCT03505762
Oct 10th, 2022 - PRIMARY OBJECTIVES: I. To compare the cumulative incidence of hyperglycemia after 3 cycles of treatment between standard or tailored rituximab, cyclophosphamide, doxorubicin hydrochloride, vincristine sulfate and prednisone (R-CHOP) chemotherapy. ...
https://clinicaltrials.gov/ct2/show/NCT04725630
Sep 28th, 2022 - It is vital for individuals with type 2 diabetes (T2DM) to adhere to a healthy dietary pattern to maintain optimal blood glucose levels and overall health. However, the increasing costs of healthy foods is a barrier to maintaining healthful dietar...
News 14 results
https://www.medscape.com/viewarticle/939359
Oct 19th, 2020 - Dr Masakazu Aihara Measuring glycated albumin (glycoalbumin, GA) in tears could be a future way for those with diabetes to monitor their blood sugar levels noninvasively. In a 100-patient trial, levels of GA in tears were found to be strongly corr...
https://www.mdedge.com/endocrinology/article/230120/diabetes/substance-tears-could-be-used-diabetes-monitoring
Sara Freeman
Oct 16th, 2020 - Measuring glycated albumin (glycoalbumin, GA) in tears could be a future way for those with diabetes to monitor their blood sugar levels noninvasively. Dr.
https://www.medpagetoday.com/endocrinology/diabetes/73545
Jun 18th, 2018 - Clinicians can face several challenges when screening patients for type 2 diabetes. In this exclusive video, Susan E. Spratt, MD, of Duke University Medical Center in North Carolina, breaks down when to use an HbA1c test and when you need to pivot...
https://www.medpagetoday.com/endocrinology/diabetes/62013
Dec 12th, 2016 - Simple metrics, including biomarker and anthropometric measures, accurately identified gestational diabetes risk among women with obesity, researchers reported. Lead author of the study, Sara White, MRCP, of King's College in London, said in a pre...
https://www.medscape.com/viewarticle/867325
Aug 17th, 2016 - I am part of a team that is trying to answer what I believe is an important clinical question: Do blacks Americans have higher A1c levels than white Americans, and if they do, why. This has been a controversy for the past decade or so What did we ...